Efficacy of Thermotherapy to Treat Cutaneous Leishmaniasis Caused byLeishmania tropicain Kabul, Afghanistan: A Randomized, Controlled Trial
Open Access
- 15 April 2005
- journal article
- research article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 40 (8) , 1148-1155
- https://doi.org/10.1086/428736
Abstract
Background. Pentavalent antimony is the agent recommended for treatment of cutaneous leishmaniasis (CL). Its use is problematic, because it is expensive and because of the potential for drug-associated adverse effects during a lengthy and painful treatment course. Methods. We tested the efficacy of thermotherapy for the treatment of CL due to Leishmania tropica in a randomized, controlled trial in Kabul, Afghanistan. We enrolled 401 patients with a single CL lesion and administered thermotherapy using radio-frequency waves (1 treatment of ⩾1 consecutive application at 50°C for 30 s) or sodium stibogluconate (SSG), administered either intralesionally (a total of 5 injections of 2–5 mL every 5–7 days, depending on lesion size) or intramuscularly (20 mg/kg daily for 21 days). Results. Cure, defined as complete reepithelialization at 100 days after treatment initiation, was observed in 75 (69.4%) of 108 patients who received thermotherapy, 70 (75.3%) of 93 patients who received intralesional SSG, and 26 (44.8%) of 58 patients who received intramuscular SSG. The OR for cure with thermotherapy was 2.80 (95% confidence interval [CI], 1.45–5.41), compared with intramuscular SSG treatment (P = .002). No statistically significant difference was observed in the odds of cure in comparison of intralesional SSG and thermotherapy treatments. The OR for cure with intralesional SSG treatment was 3.75 (95% CI, 1.86–7.54), compared with intramuscular SSG treatment (P < .001). The time to cure was significantly shorter in the thermotherapy group (median, 53 days) than in the intralesional SSG or intramuscularly SSG group (median, 75 days and >100 days, respectively; P = .003). Conclusions. Thermotherapy is an effective, comparatively well-tolerated, and rapid treatment for CL, and it should be considered as an alternative to antimony treatment.Keywords
This publication has 24 references indexed in Scilit:
- Leishmaniasis– current chemotherapy and recent advances in the search for novel drugsTrends in Parasitology, 2003
- Anthroponotic Cutaneous Leishmaniasis, Kabul, AfghanistanEmerging Infectious Diseases, 2003
- Leishmaniasis: Current Status of Vaccine DevelopmentClinical Microbiology Reviews, 2001
- Cutaneous leishmaniasis: Clinical aspectPublished by Elsevier ,1999
- Selective heat therapy in cutaneous leishmaniasis: a preliminary experience using the 585 nm pulsed dye laserJournal of the European Academy of Dermatology and Venereology, 1997
- Polymorphic structure of the tumor necrosis factor (TNF) locus: an NcoI polymorphism in the first intron of the human TNF-beta gene correlates with a variant amino acid in position 26 and a reduced level of TNF-beta production.The Journal of Experimental Medicine, 1991
- Treatment of Cutaneous Leishmaniasis with Infrared HeatInternational Journal of Dermatology, 1986
- Observations on Local Heat Treatment for Cutaneous LeishmaniasisThe American Journal of Tropical Medicine and Hygiene, 1984
- Thermosensitivity Patterns of Old vs. New World Cutaneous Strains of Leishmania Growing within Mouse Peritoneal Macrophages in Vitro *The American Journal of Tropical Medicine and Hygiene, 1983
- Effect of Temperature on Multiplication of Leishmania Amastigotes within Human Monocyte-Derived Macrophages in VitroThe American Journal of Tropical Medicine and Hygiene, 1981